Clinical practice guidelines for glycogen storage disease V & VII (McArdle disease and Tarui disease) from an international study group

Affiliations

• ¹ Faculty of Sports Sciences, Universidad Europea de Madrid, Spain; Centro de Investigación Biomédica en Red en Fragilidad y Envejecimiento Saludable (CIBERFES) and Research Institute of the Hospital 12 de Octubre ('imas12', PaHerg group), Madrid, Spain.
• ² Conegliano Research Centre, IRCCS Eugenio Medea, Italy.
• ³ Institut d'Investigació Germans Trias i Pujol, Camí de les Escoles, Barcelona, Spain.
• ⁴ MRC Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, London, UK.
• ⁵ International Association for Muscle Glycogen Storage Disease, California, USA. Electronic address: stacey.reason@iamgsd.org.
• ⁶ Biochemical Genetics Laboratory, Duke Health, Durham, North Carolina, USA.
• ⁷ Department of Sport Health and Exercise Sciences, Brunel University, Uxbridge, UK.
• ⁸ University of Texas, Southwestern Medical Center, Dallas, USA.
• ⁹ Department of Pediatrics, Duke University School of Medicine, Durham, USA.
• ¹⁰ Neurology Department, Raymond-Poincaré Teaching Hospital, Garches, France.
• ¹¹ Copenhagen Neuromuscular Center, Rigshospitalet, Copenhagen, Denmark.
• ¹² Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
• ¹³ U.O.C. di Neurologia e Malattie Neuromuscolari, Dipartimento di Neuroscienze, Messina, Italy.
• ¹⁴ Pablo de Olavide University, Seville, Spain.
• ¹⁵ McMaster University, Health Sciences Centre, Toronto, Canada.
• ¹⁶ U.O.C. di Neurologia e Malattie Neuromuscolari, Dipartimento di Neuroscienze, Messina, Ital.
• ¹⁷ Association for Glycogen Storage Disease, UK.